NCT02358395 A Study of BBI608 Administrated With Sorafenib in Adult Patients With Advanced Hepatocellular Carcinoma Status COMPLETED Phase PHASE1
NCT02354898 A Study of BBI503 in Advanced Solid Tumors, or BBI503/ Sorafenib in Advanced Hepatocellular Carcinoma Status COMPLETED Phase PHASE1
NCT02329821 Change of Lactate Concentration During Hartmann Solution Infusion for Hepatic Resection Status COMPLETED Phase N/A
NCT02323360 A Trial on SBRT After Incomplete TAE or TACE Versus Exclusive TAE or TACE For Treatment of Inoperable HCC Status TERMINATED Phase NA
NCT02314052 Phase Ib/2, Multicenter, Dose Escalation Study of DCR-MYC in Patients With Hepatocellular Carcinoma Status TERMINATED Phase PHASE1/PHASE2
NCT02311205 Efficacy and Safety of Concurrent TACE and Sorafenib in Patients With HCC and Extrahepatic Metastasis (COTSOM Study) Status UNKNOWN Phase PHASE2
NCT02309788 Radiotherapy in Hepatocellular Carcinomas After Hepatectomy With Narrow Margin (<1 cm) or Portal Vein Thrombosis Status UNKNOWN Phase N/A
NCT02304289 Dose-Escalation Study Evaluating the Safety and Pharmacokinetics of Artesunate in Patients With Hepatocellular Carcinoma Status TERMINATED Phase PHASE1
NCT02290977 Transarterial Chemoembolization (TACE) With Radiation Therapy (RT) in Advanced Hepatocellular Carcinoma (HCC) Status UNKNOWN Phase PHASE2
NCT02289300 A Study to Evaluate a Study Drug, DCB-BO1202, for Alleviating Liver Fibrosis in Liver Cancer Patients Status WITHDRAWN Phase PHASE2
NCT02288910 Blood Volume Assessment of Hepatocellular and Metastatic Carcinomas in the Liver Status COMPLETED Phase N/A
NCT02279719 A Study of BBI608 in Combination With Sorafenib, or BBI503 in Combination With Sorafenib in Adult Patients With Hepatocellular Carcinoma Status COMPLETED Phase PHASE1/PHASE2
NCT02273362 Erlotinib Hydrochloride in Preventing Liver Cancer in Patients With Cirrhosis of the Liver Status COMPLETED Phase PHASE1/PHASE2
NCT02269995 Post-marketing Surveillance of DC Bead in Patients With Hepatocellular Carcinoma Status COMPLETED Phase N/A